Liu J - Search Results

1

Analysis of miR-205 and miR-155 expression in the blood of breast cancer patients.

Liu J, Mao Q, Liu Y, Hao X, Zhang S, Zhang J. Liu J, et al. Among authors: liu y. Chin J Cancer Res. 2013 Feb;25(1):46-54. doi: 10.3978/j.issn.1000-9604.2012.11.04. Chin J Cancer Res. 2013. PMID: 23372341 Free PMC article.

2

[Prognostic significance of Ki-67 expression before and after neoadjuvant chemotherapy in different biological breast cancer phenotypes].

Liu Y, Zhang X, Yu F, Liu J, Zhang M, Zhang S, Hao X, Zhang J. Liu Y, et al. Among authors: liu j. Zhonghua Zhong Liu Za Zhi. 2014 Sep;36(9):671-6. Zhonghua Zhong Liu Za Zhi. 2014. PMID: 25564057 Chinese.

3

MiR-340 Inhibits Triple-Negative Breast Cancer Progression by Reversing EZH2 Mediated miRNAs Dysregulated Expressions.

Shi Z, Li Y, Qian X, Hu Y, Liu J, Zhang S, Zhang J. Shi Z, et al. Among authors: liu j. J Cancer. 2017 Sep 2;8(15):3037-3048. doi: 10.7150/jca.19315. eCollection 2017. J Cancer. 2017. PMID: 28928895 Free PMC article.

4

A pilot randomized clinical study of the additive treatment effect of photodynamic therapy in breast cancer patients with chest wall recurrence.

Liu Y, Hou G, Zhang X, Liu JJ, Zhang S, Zhang J. Liu Y, et al. Among authors: liu jj. J Breast Cancer. 2014 Jun;17(2):161-6. doi: 10.4048/jbc.2014.17.2.161. Epub 2014 Jun 27. J Breast Cancer. 2014. PMID: 25013438 Free PMC article.

5

Breast-conserving therapy versus modified radical mastectomy: socioeconomic status determines who receives what--results from case-control study in Tianjin, China.

Liu JJ, Zhang S, Hao X, Xie J, Zhao J, Wang J, Liu L, Wang PP, Zhang J. Liu JJ, et al. Among authors: liu l. Cancer Epidemiol. 2012 Feb;36(1):89-93. doi: 10.1016/j.canep.2011.04.005. Epub 2011 May 25. Cancer Epidemiol. 2012. PMID: 21613000

6

Efficacy and feasibility of the immunomagnetic separation based diagnosis for detecting sentinel lymph node metastasis from breast cancer.

Zhi XC, Zhang M, Meng TT, Zhang XB, Shi ZD, Liu Y, Liu JJ, Zhang S, Zhang J. Zhi XC, et al. Among authors: liu jj, liu y. Int J Nanomedicine. 2015 Apr 7;10:2775-84. doi: 10.2147/IJN.S72263. eCollection 2015. Int J Nanomedicine. 2015. PMID: 25897222 Free PMC article.

7

Body mass index and diabetes are important prognostic signatures for bilateral breast cancer prognosis.

Zhang M, Zhang X, Liu J, Su W, Li J, Zhang S, Zhang J. Zhang M, et al. Among authors: liu j. J Cell Biochem. 2019 May;120(5):7363-7374. doi: 10.1002/jcb.28011. Epub 2019 Jan 7. J Cell Biochem. 2019. PMID: 30618092

8

Correlation of radiotherapy with prognosis of elderly patients with hormone receptor-positive breast cancer according to immunohistochemical subtyping.

Zhi X, Yang X, Pan T, Liu J, Chen X, Lou L, Shi Z, Zhang J. Zhi X, et al. Among authors: liu j. Chin J Cancer Res. 2019 Jun;31(3):471-480. doi: 10.21147/j.issn.1000-9604.2019.03.09. Chin J Cancer Res. 2019. PMID: 31354216 Free PMC article.

9

FBXL19-AS1 promotes cell proliferation and inhibits cell apoptosis via miR-876-5p/FOXM1 axis in breast cancer.

Dong G, Pan T, Zhou D, Li C, Liu J, Zhang J. Dong G, et al. Among authors: liu j. Acta Biochim Biophys Sin (Shanghai). 2019 Nov 18;51(11):1106-1113. doi: 10.1093/abbs/gmz110. Acta Biochim Biophys Sin (Shanghai). 2019. PMID: 31696201 Free article.

10

T-cell receptors provide potential prognostic signatures for breast cancer.

Liu J, Zhang J. Liu J, et al. Cell Biol Int. 2021 Jun;45(6):1220-1230. doi: 10.1002/cbin.11562. Epub 2021 Mar 11. Cell Biol Int. 2021. PMID: 33527533

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

147,732 results

Search Page

Filters